Pretransplant C-reactive protein as a prognostic marker in allogeneic stem cell transplantation: A PRISMA-compliant meta-analysis

Medicine
Peilin WuWei Wang

Abstract

Numerous reports have explored the prognostic value of pretransplant serum C-reactive protein (CRP) in patients receiving allogeneic stem cell transplant (ASCT), but the results remain conflicting. Therefore, we performed a meta-analysis to comprehensively assess the prognostic value of pretransplant serum CRP in patients receiving ASCT. We systematically searched eligible studies in PubMed, Embase, and Web of Science from 1999 to September 2018. The pooled hazard ratios (HRs) and their corresponding 95% CIs were used to synthetically assess the prognostic value of pre-ASCT CRP in terms of overall survival (OS), non-relapse mortality (NRM), and acute graft versus host disease (aGVHD). A total of 14 articles with 15 studies containing 3458 patients were included in this meta-analysis. The pooled results showed that high pre-ASCT CRP level was significantly related to worse OS (HR = 1.63; 95% CI: 1.34-1.98; P < .05), to an increased risk of NRM (HR = 2.06; 95% CI: 1.62-2.62; P < .05), and aGVHD (HR = 1.35; 95% CI: 1.07-1.71; P < .05). Additionally, sensitivity and subgroup analyses demonstrated that our pooled results were stable and reliable. High pre-ASCT serum CRP was significantly associated with worse OS, as well as higher r...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Mar 22, 2006·Annals of Internal Medicine·Tanyalak ParimonJason W Chien
Apr 14, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Hsu-Ko KuoSuzanne G Leveille
Apr 16, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Shigeo FujiYoichi Takaue
Oct 23, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andrew S ArtzKoen van Besien
Jan 27, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Keisuke KataokaMineo Kurokawa
Nov 5, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Isao TawaraPavan Reddy
Dec 15, 2010·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Karsten KnoblochPeter M Vogt
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John T HoranMarcelo C Pasquini
Mar 15, 2011·Bone Marrow Transplantation·G N BazuayeM Stern
Jun 7, 2011·Bone Marrow Transplantation·A Gratwohl
Dec 6, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Alexander Krüttgen, Stefan Rose-John
Dec 10, 2013·Scandinavian Journal of Immunology·K K I JordanK G Müller
Apr 24, 2015·Age and Ageing·Sujarwoto Sujarwoto, Gindo Tampubolon
Apr 12, 2016·Frontiers in Immunology·Martin Szyska, Il-Kang Na
Jun 9, 2016·Bone Marrow Transplantation·M Elsawy, M L Sorror
Nov 2, 2016·Haematologica·Andrew S ArtzUNKNOWN from the Center for International Blood and Marrow Transplantation Research
Nov 4, 2016·International Journal of Molecular Sciences·Tor Henrik TvedtØystein Bruserud

❮ Previous
Next ❯

Software Mentioned

Engauge Digitizer
Stata

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.